Ibogaine Produces Neurodegeneration in Rat, but Not Mouse, Cerebellum
Open Access
- 1 October 1996
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 801 (1) , 217-226
- https://doi.org/10.1111/j.1749-6632.1996.tb17444.x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complexNeuroscience Letters, 1995
- The inhibitory effect of norharman on morphine withdrawal syndrome in rats: Comparison with ibogaineBehavioural Brain Research, 1994
- A preliminary investigation of ibogaine: Case reports and recommendations for further studyJournal of Substance Abuse Treatment, 1994
- The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complexPsychopharmacology, 1994
- Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamineBrain Research, 1992
- Effects of ibogaine on acute signs of morphine withdrawal in rats: Independence from tremorNeuropharmacology, 1992
- Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in ratsBrain Research, 1992
- Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studiesBrain Research, 1992
- Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis studyEuropean Journal of Pharmacology, 1991
- Effects and aftereffects of ibogaine on morphine self-administration in ratsEuropean Journal of Pharmacology, 1991